申请人:CUENOUD Bernard
公开号:US20150065490A1
公开(公告)日:2015-03-05
Compounds of formula I
in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β
2
-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公式I的化合物,无论是自由形式、盐形式或溶剂形式,其中X的意义在说明书中指示,可用于治疗通过激活β2-肾上腺素受体预防或缓解的疾病。还描述了含有这些化合物的制药组合物以及制备这些化合物的过程。